These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6535330)

  • 1. Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.
    Waltman SR
    Trans Am Ophthalmol Soc; 1984; 82():827-49. PubMed ID: 6535330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
    Krupin T; Waltman SR
    Jpn J Ophthalmol; 1985; 29(2):139-45. PubMed ID: 4046222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitreous fluorophotometry in juvenile diabetes.
    Kernell A; Larsson Y; Ludvigsson J; Tenland T
    Acta Endocrinol Suppl (Copenh); 1980; 238():67-74. PubMed ID: 6933816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of early retinal changes in diabetes by vitreous fluorophotometry.
    Cunha-Vaz JG; Fonseca JR; Abreu JF; Ruas MA
    Diabetes; 1979 Jan; 28(1):16-9. PubMed ID: 759246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of vitreous fluorophotometry to distinguish between diabetics with and without observable retinopathy: effect of vitreous abnormalities on the measurement.
    Prager TC; Chu HH; Garcia CA; Anderson RE; Field JB; Orzeck EA; Comstock JP
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):57-65. PubMed ID: 6826315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
    Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A
    Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous fluorophotometry in juvenile-onset diabetes mellitus.
    Krupin T; Waltman SR; Oestrich C; Santiago J; Ratzan S; Kilo C; Becker B
    Arch Ophthalmol; 1978 May; 96(5):812-4. PubMed ID: 655917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fluorophotometric study of juvenile insulin-dependent diabetic patients].
    Domosławski M; Skopiński P; Trippenbach H
    Klin Oczna; 1998; 100(6):369-71. PubMed ID: 10067063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
    Larsen M
    Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous fluorophotometric evaluation of diabetics.
    Bursell SE; Delori FC; Yoshida A; Parker JS; Collas GD; McMeel JW
    Invest Ophthalmol Vis Sci; 1984 Jun; 25(6):703-10. PubMed ID: 6724841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular fluorophotometry in insulin-treated diabetic patients with and without retinopathy.
    Kjaergaard JJ; Ohrt V
    Int J Microcirc Clin Exp; 1983; 2(3):207-13. PubMed ID: 6381356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
    Retina; 1995; 15(2):134-40. PubMed ID: 7624601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic control.
    White NH; Waltman SR; Krupin T; Santiago JV
    Diabetes; 1982 Jan; 31(1):80-5. PubMed ID: 6759217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surveillance using vitreo-fluoro-photometry of diabetics treated with an insulin pump, without or with minimal retinopathy. Results after 3 years].
    Bordat B; Misse P; Zaluski S; Rouault R; Mirouze J
    J Fr Ophtalmol; 1989; 12(6-7):421-5. PubMed ID: 2636237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early diagnosis of diabetic retinopathy in patients with diabetes type I, using vitreous fluorophotometry].
    Janiec S; Sośnierz-Jupowiecka A; Rzendkowski M
    Klin Oczna; 1994; 96(8-9):265-7. PubMed ID: 7897991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fluorophotometry of the vitreous body in diabetics without retinopathy or with minimal retinopathy].
    Bordat B; Guirgis IR; Manderscheid JC
    J Fr Ophtalmol; 1990; 13(6-7):343-7. PubMed ID: 2290006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of selected cellular adhesion molecules and proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy].
    Adamiec J; Oficjalska-Młyńczak J
    Przegl Lek; 2007; 64(6):389-92. PubMed ID: 18159844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreous variation in vitreous fluorophotometry.
    Ross S; Arffa R; Miller D; Weiss JN; Ransil BJ
    Ann Ophthalmol; 1982 Mar; 14(3):245-9. PubMed ID: 7092034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fluorescein angiography in children and adolescents with type I diabetes mellitus].
    Urban B; Bakunowicz-Lazarczyk A; Peczyńska J; Urban M
    Klin Oczna; 1999; 101(3):191-4. PubMed ID: 10526443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
    Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.